Chun-Hsiang Hsu

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 25, 2026
Empirical Osimertinib as a Second-Line Treatment Is a Viable Option Following First- and Second-Generation TKI Therapy With Unknown EGFR Status in Treated Non-Small Cell Lung Cancer: A Retrospective Study.

Pageof 1

Frequent Collaborators

1 joint publications

Chiu-Fan Chen

1 joint publications

Wei-Cheng Hong